$Coeptis Therapeutics (COEP.US)$ Coeptis Therapeutics Holdin...

$Coeptis Therapeutics (COEP.US)$ Coeptis Therapeutics Holdings (NASDAQ: COEP) has announced a 1-for-20 reverse stock split effective December 31, 2024. Upon implementation, every 20 shares of outstanding common stock will be converted into one share, with fractional shares rounded up to the next whole number. The reverse split aims to help the company meet Nasdaq Capital Market's minimum bid price requirement of $1.00 per share.

The split was approved by stockholders on December 18, 2024, and will not alter stockholders' percentage interest in the company's outstanding common stock, except for adjustments from fractional share treatment. Continental Stock Transfer is serving as the exchange agent, with stockholders holding shares in brokerage accounts not required to take any action.